My News
Personalise your news feed by choosing your favourite topics of interest
Image: Shutterstock/Lestertair
Image: Shutterstock/Lestertair
A BATCH OF adrenaline pens used to treat allergic reactions is being recalled.
The recall of the Emerade pens was announced today by the Health Products Regulatory Authority (HPRA).
The decision to recall a batch of the pens was made after some Emerade pens in other countries failed to produce an injection and failed to activate, with the potential for a blocked needle.
The pen is an emergency treatment for anaphylaxis.
The recall covers batches of:
- 150mcg pre-filled Emerade pens
- 300mcg pre-filled Emerade pens
- 500mcg pre-filled Emerade pens
Anyone who has an Emerade pen has been told by HPRA to return it to their local pharmacy and get it replaced with an alternative product.
The cause of the activation failure is unknown, as is rate of the defect in the pen.
COMMENTS (7)